These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 5316291

  • 1. Anticoagulants produced by thrombin from fibrin, the effect on blood coagulation, some physical characteristics.
    Muirhead CR, Triantaphyllopoulos DC.
    Thromb Diath Haemorrh; 1971 Oct 31; 26(2):211-23. PubMed ID: 5316291
    [No Abstract] [Full Text] [Related]

  • 2. Formation of anticoagulants by digesting fibrin with thrombin.
    Triantaphyllopoulos DC, Muirhead CR.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):397-402. PubMed ID: 5304346
    [No Abstract] [Full Text] [Related]

  • 3. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK, Mitchell PS, Gorstein F.
    Thromb Diath Haemorrh; 1967 May 31; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract] [Full Text] [Related]

  • 4. Properties of thrombin and fibrinolysin lysed fibrin.
    Triantaphyllopoulos DC, Muirhead CR, Triantaphyllopoulos E.
    Thromb Diath Haemorrh Suppl; 1969 May 31; 36():269-76. PubMed ID: 5375545
    [No Abstract] [Full Text] [Related]

  • 5. Fibrinogen derivatives. A laboratory and clinical study.
    Vermylen J.
    Verh K Vlaam Acad Geneeskd Belg; 1972 May 31; 34(2):125-208. PubMed ID: 4278099
    [No Abstract] [Full Text] [Related]

  • 6. [Functional state of the anticoagulation system during intravenous administration of fibrin monomer].
    Kudriashov BA, Molchanova LV, Kalishevskaia TM, Bazaz'ian GG, Pastorova VE, Sytina NP.
    Vopr Med Khim; 1969 May 31; 15(5):483-6. PubMed ID: 5368085
    [No Abstract] [Full Text] [Related]

  • 7. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E.
    Acta Physiol Scand Suppl; 1969 May 31; 325():1-41. PubMed ID: 4900570
    [No Abstract] [Full Text] [Related]

  • 8. Preferential degradation of soluble fibrin monomers in streptokinase-activated plasma.
    Konttinen YP, Lalla ML, Turunen O.
    Thromb Diath Haemorrh; 1973 Nov 31; 30(2):403-13. PubMed ID: 4543990
    [No Abstract] [Full Text] [Related]

  • 9. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU, Hansen MS, Smith GF, Latallo ZS, Chang ML, Mattler LE.
    Ser Haematol; 1973 Nov 31; 6(4):494-512. PubMed ID: 4277578
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(3):391-404. PubMed ID: 5314899
    [No Abstract] [Full Text] [Related]

  • 11. Studies on the thrombin clotting time. I. The influence of fibrinogen degradation products.
    Arnesen H, Godal HC.
    Scand J Haematol; 1973 Jun 30; 10(3):232-40. PubMed ID: 4797626
    [No Abstract] [Full Text] [Related]

  • 12. Separation and estimation split "products" of fibrinogen and fibrin in human serum.
    Niléhn JE.
    Thromb Diath Haemorrh; 1967 Dec 31; 18(3-4):487-98. PubMed ID: 4952978
    [No Abstract] [Full Text] [Related]

  • 13. Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer.
    Smith GF, Bang NU.
    Biochemistry; 1972 Aug 01; 11(16):2958-66. PubMed ID: 4261258
    [No Abstract] [Full Text] [Related]

  • 14. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA, Meijers JC, Bouma BN.
    Thromb Haemost; 1996 Sep 01; 76(3):347-53. PubMed ID: 8883269
    [Abstract] [Full Text] [Related]

  • 15. Fibrin gel formation in a shear flow.
    Guy RD, Fogelson AL, Keener JP.
    Math Med Biol; 2007 Mar 01; 24(1):111-30. PubMed ID: 17018571
    [Abstract] [Full Text] [Related]

  • 16. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
    Del Principe D, Strappini PM, Del Vecchio S, Menichelli A, Biancini G, Cosmi EV, Bastianon V, D'Arcangelo C.
    Thromb Haemost; 1981 Oct 01; 46(3):581-3. PubMed ID: 7031980
    [Abstract] [Full Text] [Related]

  • 17. Modulation of thrombin and heparin activities by fibrin.
    Hogg PJ, Bock PE.
    Thromb Haemost; 1997 Mar 01; 77(3):424-33. PubMed ID: 9065987
    [No Abstract] [Full Text] [Related]

  • 18. Coagulation inhibitor elicited by thrombin.
    Marciniak E.
    Science; 1970 Oct 23; 170(3956):452-3. PubMed ID: 5466707
    [Abstract] [Full Text] [Related]

  • 19. Amino acids and peptides XII: synthetic peptides related to the N-terminal portion of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
    Kawasaki K, Hirase K, Tsuji T, Miyano M, Iwamoto M.
    Thromb Res; 1989 Dec 15; 56(6):757-62. PubMed ID: 2633403
    [No Abstract] [Full Text] [Related]

  • 20. [Heparin complex formation with plasma fibrin-stabilizing factor in vitro].
    Ul'ianov AM, Kudriashov BA, Liapina LA.
    Biokhimiia; 1973 Dec 15; 38(6):1281-7. PubMed ID: 4802010
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.